DXCM earnings call for the period ending December 31, 2024.

DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

Now that we're a month out from CES, these are the trends that have stuck with me. Yes, AI is on the list, of course, but so ...

Leonardo DRS, Inc. announced today that it was awarded a contract to provide and integrate the latest Battle Management Systems (BMS) C4I hardware and software into new Royal Thailand Army combat ...

Epitel, Inc., a leader in AI technologies for patient-focused brain health solutions, is pleased to announce that Steve Pacelli has been appointed as the company's new Chief Executive Officer. Pacelli ...

Advanced Magnetic Sensing (AMS) non-contact displacement sensors are designed for materials research and development, and ...

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...